Drug-coated stent implantation vs. bypass surgery for in-stent occlusion after femoropopliteal stenting View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-01-04

AUTHORS

Yusuke Tomoi, Yoshimitsu Soga, Jin Okazaki, Osamu Iida, Tatsuya Shiraki, Seiichi Hiramori, Kenji Ando

ABSTRACT

The optimal revascularization for in-stent occlusion (ISO) lesions after femoropopliteal (FP) bare-nitinol stenting has not been established. We, therefore, investigated the comparison between drug-coated stent (DCS) implantation and bypass surgery (BSX) for ISO lesions after FP bare-nitinol stenting. This study was a dual-center, observational study from January 2004 to December 2015. A total of 172 ISO lesions were observed, and after excluding 120 ISO lesions, 52 ISO lesions (50 patients; mean age, 71.0 ± 9.2 years; male, 59.6%) after FP bare-nitinol stenting were enrolled. The included patients with clinical symptoms underwent either DCS implantation (n = 28) or BSX (n = 22). The primary endpoint was recurrent in-stent restenosis (ReISR); secondary endpoints were recurrent target lesion revascularization (ReTLR), recurrent occlusion (reocclusion) and major adverse limb events (MALE), and perioperative complications (POCs), respectively. ReISR or reocclusion was defined as ISR or occlusion after TLR. Stent restenosis was defined as a peak systolic velocity ratio (PSVR) > 2.4 on a duplex scan or ≥ 50% stenosis on angiography. Graft restenosis was defined as a PSV > 300 cm/s and velocity ratio 3.5 or uniformly low PSV < 45 cm/s throughout the entire graft based on graft surveillance. The mean follow-up period was 36.6 ± 25.5 months. At 2 years, the rates of freedom from ReISR, ReTLR, and MALE were not significantly different between the DCS implantation and BSX groups (68.9% vs. 73.7%, p = 0.81; 84.7% vs. 73.7%, p = 0.45; 84.7% vs. 78.6%, p = 0.60, respectively). However, the freedom from reocclusion rate was significantly lower in the DCS implantation group (81.6% vs. 100%, p = 0.04). The occurrence of POCs was not significantly different between the DCS implantation and BSX groups (7.1% vs 4.2%, p = 1.0). Although BSX was the gold-standard therapy for ISO lesions after FP bare-nitinol stenting, DCS implantation might be a good option because the rates of freedom from ReISR, ReTLR, and MALE were similar. More... »

PAGES

646-653

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00380-020-01740-8

DOI

http://dx.doi.org/10.1007/s00380-020-01740-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1134295127

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33392645


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endovascular Procedures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Femoral Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peripheral Arterial Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Popliteal Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prosthesis Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Patency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomoi", 
        "givenName": "Yusuke", 
        "id": "sg:person.01104331243.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104331243.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soga", 
        "givenName": "Yoshimitsu", 
        "id": "sg:person.01276714415.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276714415.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Vascular Surgery, Kokura Memorial Hospital, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Vascular Surgery, Kokura Memorial Hospital, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okazaki", 
        "givenName": "Jin", 
        "id": "sg:person.0626222606.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626222606.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kansai Rosai Hospital, Amagasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.414976.9", 
          "name": [
            "Department of Cardiology, Kansai Rosai Hospital, Amagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iida", 
        "givenName": "Osamu", 
        "id": "sg:person.01016335235.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016335235.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shiraki", 
        "givenName": "Tatsuya", 
        "id": "sg:person.01021665142.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021665142.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hiramori", 
        "givenName": "Seiichi", 
        "id": "sg:person.01013656366.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013656366.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ando", 
        "givenName": "Kenji", 
        "id": "sg:person.01014341104.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014341104.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00380-020-01697-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1130621190", 
          "https://doi.org/10.1007/s00380-020-01697-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-020-01730-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1132792794", 
          "https://doi.org/10.1007/s00380-020-01730-w"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-020-01631-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1127943007", 
          "https://doi.org/10.1007/s00380-020-01631-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-01-04", 
    "datePublishedReg": "2021-01-04", 
    "description": "The optimal revascularization for in-stent occlusion (ISO) lesions after femoropopliteal (FP) bare-nitinol stenting has not been established. We, therefore, investigated the comparison between drug-coated stent (DCS) implantation and bypass surgery (BSX) for ISO lesions after FP bare-nitinol stenting. This study was a dual-center, observational study from January 2004 to December 2015. A total of 172 ISO lesions were observed, and after excluding 120 ISO lesions, 52 ISO lesions (50 patients; mean age, 71.0\u2009\u00b1\u20099.2\u00a0years; male, 59.6%) after FP bare-nitinol stenting were enrolled. The included patients with clinical symptoms underwent either DCS implantation (n\u2009=\u200928) or BSX (n\u2009=\u200922). The primary endpoint was recurrent in-stent restenosis (ReISR); secondary endpoints were recurrent target lesion revascularization (ReTLR), recurrent occlusion (reocclusion) and major adverse limb events (MALE), and perioperative complications (POCs), respectively. ReISR or reocclusion was defined as ISR or occlusion after TLR. Stent restenosis was defined as a peak systolic velocity ratio (PSVR)\u2009>\u20092.4 on a duplex scan or\u2009\u2265\u200950% stenosis on angiography. Graft restenosis was defined as a PSV\u2009>\u2009300\u00a0cm/s and velocity ratio 3.5 or uniformly low PSV\u2009<\u200945\u00a0cm/s throughout the entire graft based on graft surveillance. The mean follow-up period was 36.6\u2009\u00b1\u200925.5\u00a0months. At 2\u00a0years, the rates of freedom from ReISR, ReTLR, and MALE were not significantly different between the DCS implantation and BSX groups (68.9% vs. 73.7%, p\u2009=\u20090.81; 84.7% vs. 73.7%, p\u2009=\u20090.45; 84.7% vs. 78.6%, p\u2009=\u20090.60, respectively). However, the freedom from reocclusion rate was significantly lower in the DCS implantation group (81.6% vs. 100%, p\u2009=\u20090.04). The occurrence of POCs was not significantly different between the DCS implantation and BSX groups (7.1% vs 4.2%, p\u2009=\u20091.0). Although BSX was the gold-standard therapy for ISO lesions after FP bare-nitinol stenting, DCS implantation might be a good option because the rates of freedom from ReISR, ReTLR, and MALE were similar.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00380-020-01740-8", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1095887", 
        "issn": [
          "0910-8327", 
          "1615-2573"
        ], 
        "name": "Heart and Vessels", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "keywords": [
      "major adverse limb events", 
      "peak systolic velocity ratio", 
      "rate of freedom", 
      "DCS implantation", 
      "perioperative complications", 
      "bypass surgery", 
      "stent implantation", 
      "stent restenosis", 
      "BSx group", 
      "recurrent target lesion revascularization", 
      "target lesion revascularization", 
      "adverse limb events", 
      "gold standard therapy", 
      "systolic velocity ratio", 
      "optimal revascularization", 
      "reocclusion rate", 
      "occlusion lesions", 
      "primary endpoint", 
      "secondary endpoints", 
      "lesion revascularization", 
      "mean follow", 
      "duplex scan", 
      "clinical symptoms", 
      "graft surveillance", 
      "recurrent occlusion", 
      "stent occlusion", 
      "femoropopliteal stenting", 
      "observational study", 
      "implantation group", 
      "graft restenosis", 
      "entire graft", 
      "stenting", 
      "limb events", 
      "lesions", 
      "restenosis", 
      "lower PSV", 
      "revascularization", 
      "occlusion", 
      "implantation", 
      "surgery", 
      "endpoint", 
      "PSV", 
      "group", 
      "BSX", 
      "reocclusion", 
      "complications", 
      "stenosis", 
      "patients", 
      "angiography", 
      "TLR", 
      "best option", 
      "graft", 
      "therapy", 
      "symptoms", 
      "follow", 
      "months", 
      "scans", 
      "rate", 
      "total", 
      "surveillance", 
      "study", 
      "options", 
      "years", 
      "ISR", 
      "period", 
      "velocity ratio", 
      "occurrence", 
      "events", 
      "ratio 3.5", 
      "ratio", 
      "comparison", 
      "freedom"
    ], 
    "name": "Drug-coated stent implantation vs. bypass surgery for in-stent occlusion after femoropopliteal stenting", 
    "pagination": "646-653", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1134295127"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00380-020-01740-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33392645"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00380-020-01740-8", 
      "https://app.dimensions.ai/details/publication/pub.1134295127"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_890.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00380-020-01740-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-020-01740-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-020-01740-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-020-01740-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-020-01740-8'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      115 URIs      104 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00380-020-01740-8 schema:about N1c99994b5da24a53868de797ea63c283
2 N35d763d642e545a797802265560ccd64
3 N365a4f24e689425b8ca61234a14a9465
4 N3d18029d254945f29c3f644f44d84a30
5 N6294f840213640cfa7585b0ef7b8eb4a
6 N84dc6d4bacba458dafcd3888043dc6fc
7 N85ca58ba53bc4b0e84cf6f84e1bd38ec
8 N97d676cf04d64fa88dc534db13fd8e61
9 Na3b6a269695a4ff59f4d73219fde7928
10 Nc17aae5357d44de99252dc895b181ab7
11 Nd08a837ff3ba47f99cf5b803c9813cc3
12 Nd75ad42111b5475f92fe72ee2514f32d
13 Ne9fa1117c4a442999afc4f3e26d0e582
14 Ne9fcb30397b045d8a4b95a7e0dee034d
15 Nef107cf302c74c8aba0d68e937e84af6
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author Nab288edc954b4edea6ebcb8680449403
19 schema:citation sg:pub.10.1007/s00380-020-01631-y
20 sg:pub.10.1007/s00380-020-01697-8
21 sg:pub.10.1007/s00380-020-01730-w
22 schema:datePublished 2021-01-04
23 schema:datePublishedReg 2021-01-04
24 schema:description The optimal revascularization for in-stent occlusion (ISO) lesions after femoropopliteal (FP) bare-nitinol stenting has not been established. We, therefore, investigated the comparison between drug-coated stent (DCS) implantation and bypass surgery (BSX) for ISO lesions after FP bare-nitinol stenting. This study was a dual-center, observational study from January 2004 to December 2015. A total of 172 ISO lesions were observed, and after excluding 120 ISO lesions, 52 ISO lesions (50 patients; mean age, 71.0 ± 9.2 years; male, 59.6%) after FP bare-nitinol stenting were enrolled. The included patients with clinical symptoms underwent either DCS implantation (n = 28) or BSX (n = 22). The primary endpoint was recurrent in-stent restenosis (ReISR); secondary endpoints were recurrent target lesion revascularization (ReTLR), recurrent occlusion (reocclusion) and major adverse limb events (MALE), and perioperative complications (POCs), respectively. ReISR or reocclusion was defined as ISR or occlusion after TLR. Stent restenosis was defined as a peak systolic velocity ratio (PSVR) > 2.4 on a duplex scan or ≥ 50% stenosis on angiography. Graft restenosis was defined as a PSV > 300 cm/s and velocity ratio 3.5 or uniformly low PSV < 45 cm/s throughout the entire graft based on graft surveillance. The mean follow-up period was 36.6 ± 25.5 months. At 2 years, the rates of freedom from ReISR, ReTLR, and MALE were not significantly different between the DCS implantation and BSX groups (68.9% vs. 73.7%, p = 0.81; 84.7% vs. 73.7%, p = 0.45; 84.7% vs. 78.6%, p = 0.60, respectively). However, the freedom from reocclusion rate was significantly lower in the DCS implantation group (81.6% vs. 100%, p = 0.04). The occurrence of POCs was not significantly different between the DCS implantation and BSX groups (7.1% vs 4.2%, p = 1.0). Although BSX was the gold-standard therapy for ISO lesions after FP bare-nitinol stenting, DCS implantation might be a good option because the rates of freedom from ReISR, ReTLR, and MALE were similar.
25 schema:genre article
26 schema:isAccessibleForFree false
27 schema:isPartOf N160b7d47746045649c39398830e244d8
28 Nb669c55a998947aca56af0c3cc3fb9fe
29 sg:journal.1095887
30 schema:keywords BSX
31 BSx group
32 DCS implantation
33 ISR
34 PSV
35 TLR
36 adverse limb events
37 angiography
38 best option
39 bypass surgery
40 clinical symptoms
41 comparison
42 complications
43 duplex scan
44 endpoint
45 entire graft
46 events
47 femoropopliteal stenting
48 follow
49 freedom
50 gold standard therapy
51 graft
52 graft restenosis
53 graft surveillance
54 group
55 implantation
56 implantation group
57 lesion revascularization
58 lesions
59 limb events
60 lower PSV
61 major adverse limb events
62 mean follow
63 months
64 observational study
65 occlusion
66 occlusion lesions
67 occurrence
68 optimal revascularization
69 options
70 patients
71 peak systolic velocity ratio
72 period
73 perioperative complications
74 primary endpoint
75 rate
76 rate of freedom
77 ratio
78 ratio 3.5
79 recurrent occlusion
80 recurrent target lesion revascularization
81 reocclusion
82 reocclusion rate
83 restenosis
84 revascularization
85 scans
86 secondary endpoints
87 stenosis
88 stent implantation
89 stent occlusion
90 stent restenosis
91 stenting
92 study
93 surgery
94 surveillance
95 symptoms
96 systolic velocity ratio
97 target lesion revascularization
98 therapy
99 total
100 velocity ratio
101 years
102 schema:name Drug-coated stent implantation vs. bypass surgery for in-stent occlusion after femoropopliteal stenting
103 schema:pagination 646-653
104 schema:productId N5cfcb179a50b4cc98ab977f2dbe275be
105 N8ffb51f2d2004bef95fe48558139e4d8
106 Ncc91aa888eb94a7da343b7131e7e4052
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134295127
108 https://doi.org/10.1007/s00380-020-01740-8
109 schema:sdDatePublished 2022-09-02T16:06
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher N06b5738571a14f639e30bdc9f0bf60a8
112 schema:url https://doi.org/10.1007/s00380-020-01740-8
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N06b5738571a14f639e30bdc9f0bf60a8 schema:name Springer Nature - SN SciGraph project
117 rdf:type schema:Organization
118 N160b7d47746045649c39398830e244d8 schema:issueNumber 5
119 rdf:type schema:PublicationIssue
120 N1c99994b5da24a53868de797ea63c283 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Popliteal Artery
122 rdf:type schema:DefinedTerm
123 N35d763d642e545a797802265560ccd64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Humans
125 rdf:type schema:DefinedTerm
126 N365a4f24e689425b8ca61234a14a9465 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Prosthesis Design
128 rdf:type schema:DefinedTerm
129 N3d18029d254945f29c3f644f44d84a30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Angiography
131 rdf:type schema:DefinedTerm
132 N3f91f683ea4b4457a4cc4e8ef775a608 rdf:first sg:person.0626222606.63
133 rdf:rest Nbfac44ddc22f4f17b6a516f346e278c7
134 N4344eb125cda4c398fe1cf0489ecdecd rdf:first sg:person.01021665142.53
135 rdf:rest Ne773293f1e5b46c685d1cb6931884df7
136 N5cfcb179a50b4cc98ab977f2dbe275be schema:name dimensions_id
137 schema:value pub.1134295127
138 rdf:type schema:PropertyValue
139 N6294f840213640cfa7585b0ef7b8eb4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Aged
141 rdf:type schema:DefinedTerm
142 N76f835f6b153401eb8d364324bd55910 rdf:first sg:person.01014341104.13
143 rdf:rest rdf:nil
144 N84dc6d4bacba458dafcd3888043dc6fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Retrospective Studies
146 rdf:type schema:DefinedTerm
147 N85ca58ba53bc4b0e84cf6f84e1bd38ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Vascular Patency
149 rdf:type schema:DefinedTerm
150 N8ffb51f2d2004bef95fe48558139e4d8 schema:name pubmed_id
151 schema:value 33392645
152 rdf:type schema:PropertyValue
153 N97d676cf04d64fa88dc534db13fd8e61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Male
155 rdf:type schema:DefinedTerm
156 Na3b6a269695a4ff59f4d73219fde7928 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Femoral Artery
158 rdf:type schema:DefinedTerm
159 Nab288edc954b4edea6ebcb8680449403 rdf:first sg:person.01104331243.48
160 rdf:rest Nc574d83986e94fefafe3115194697ba7
161 Nb669c55a998947aca56af0c3cc3fb9fe schema:volumeNumber 36
162 rdf:type schema:PublicationVolume
163 Nbfac44ddc22f4f17b6a516f346e278c7 rdf:first sg:person.01016335235.39
164 rdf:rest N4344eb125cda4c398fe1cf0489ecdecd
165 Nc17aae5357d44de99252dc895b181ab7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Treatment Outcome
167 rdf:type schema:DefinedTerm
168 Nc574d83986e94fefafe3115194697ba7 rdf:first sg:person.01276714415.24
169 rdf:rest N3f91f683ea4b4457a4cc4e8ef775a608
170 Ncc91aa888eb94a7da343b7131e7e4052 schema:name doi
171 schema:value 10.1007/s00380-020-01740-8
172 rdf:type schema:PropertyValue
173 Nd08a837ff3ba47f99cf5b803c9813cc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Drug-Eluting Stents
175 rdf:type schema:DefinedTerm
176 Nd75ad42111b5475f92fe72ee2514f32d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Female
178 rdf:type schema:DefinedTerm
179 Ne773293f1e5b46c685d1cb6931884df7 rdf:first sg:person.01013656366.66
180 rdf:rest N76f835f6b153401eb8d364324bd55910
181 Ne9fa1117c4a442999afc4f3e26d0e582 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Follow-Up Studies
183 rdf:type schema:DefinedTerm
184 Ne9fcb30397b045d8a4b95a7e0dee034d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Endovascular Procedures
186 rdf:type schema:DefinedTerm
187 Nef107cf302c74c8aba0d68e937e84af6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Peripheral Arterial Disease
189 rdf:type schema:DefinedTerm
190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
191 schema:name Medical and Health Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
194 schema:name Clinical Sciences
195 rdf:type schema:DefinedTerm
196 sg:journal.1095887 schema:issn 0910-8327
197 1615-2573
198 schema:name Heart and Vessels
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01013656366.66 schema:affiliation grid-institutes:grid.415432.5
202 schema:familyName Hiramori
203 schema:givenName Seiichi
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013656366.66
205 rdf:type schema:Person
206 sg:person.01014341104.13 schema:affiliation grid-institutes:grid.415432.5
207 schema:familyName Ando
208 schema:givenName Kenji
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014341104.13
210 rdf:type schema:Person
211 sg:person.01016335235.39 schema:affiliation grid-institutes:grid.414976.9
212 schema:familyName Iida
213 schema:givenName Osamu
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016335235.39
215 rdf:type schema:Person
216 sg:person.01021665142.53 schema:affiliation grid-institutes:grid.136593.b
217 schema:familyName Shiraki
218 schema:givenName Tatsuya
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021665142.53
220 rdf:type schema:Person
221 sg:person.01104331243.48 schema:affiliation grid-institutes:grid.415432.5
222 schema:familyName Tomoi
223 schema:givenName Yusuke
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104331243.48
225 rdf:type schema:Person
226 sg:person.01276714415.24 schema:affiliation grid-institutes:grid.415432.5
227 schema:familyName Soga
228 schema:givenName Yoshimitsu
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276714415.24
230 rdf:type schema:Person
231 sg:person.0626222606.63 schema:affiliation grid-institutes:grid.415432.5
232 schema:familyName Okazaki
233 schema:givenName Jin
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626222606.63
235 rdf:type schema:Person
236 sg:pub.10.1007/s00380-020-01631-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1127943007
237 https://doi.org/10.1007/s00380-020-01631-y
238 rdf:type schema:CreativeWork
239 sg:pub.10.1007/s00380-020-01697-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130621190
240 https://doi.org/10.1007/s00380-020-01697-8
241 rdf:type schema:CreativeWork
242 sg:pub.10.1007/s00380-020-01730-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1132792794
243 https://doi.org/10.1007/s00380-020-01730-w
244 rdf:type schema:CreativeWork
245 grid-institutes:grid.136593.b schema:alternateName Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan
246 schema:name Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan
247 rdf:type schema:Organization
248 grid-institutes:grid.414976.9 schema:alternateName Department of Cardiology, Kansai Rosai Hospital, Amagasaki, Japan
249 schema:name Department of Cardiology, Kansai Rosai Hospital, Amagasaki, Japan
250 rdf:type schema:Organization
251 grid-institutes:grid.415432.5 schema:alternateName Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan
252 Department of Vascular Surgery, Kokura Memorial Hospital, Kitakyushu, Japan
253 schema:name Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan
254 Department of Vascular Surgery, Kokura Memorial Hospital, Kitakyushu, Japan
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...